Company Monitoring Page for Sanofi

latest headlines for company on cafepharma

The 3 Most Disappointing Drug Launches of All Time
Motley Fool
Sun, 08/23/15 - 11:49 am
Tags:
drug launches, MannKind, Afrezza, Sanofi, Zaltrap, Vivus, Arena Pharmaceuticals, Qsymia, Belviq
Lilly, Sanofi, Novo among many pharma players to throw off big price gains in H1
Fierce Pharma
Sat, 08/22/15 - 08:48 am
Tags:
Sanofi, Novo Nordisk, Eli Lilly, AstraZeneca, GSK, JNJ, stock prices
Big Pharma still a big deal for NJ economy, despite cost cuts
Fierce Pharma
Wed, 08/19/15 - 12:21 pm
Tags:
Big Pharma, New Jersey, JNJ, Merck, Novartis, Bristol-Myers Squibb, Sanofi, Bayer, Roche
Will pricey new drug classes take the wind out of diabetes launches?
Fierce Pharma Marketing
Wed, 08/19/15 - 10:01 am
Tags:
diabetes, Novo Nordisk, Eli Lilly, Boehringer Ingelheim, Sanofi
Stalwart brands from AZ, Glaxo and Sanofi top ranks of most-prescribed meds
Fierce Pharma
Mon, 08/17/15 - 11:41 am
Tags:
AstraZeneca, GSK, Sanofi, Advair, Crestor, Lantus, Nexium, Vyvanse
Sanofi adds its sales heft to Relypsa's forthcoming patiromer launch
Fierce Pharma Marketing
Sat, 08/15/15 - 10:52 am
Tags:
Sanofi, Relypsa, drug launches, drug reps, hyperkalemia, patiromer
Payers Set To Play Hardball On PCSK9 Pricing
Investors.com
Fri, 08/14/15 - 11:22 am
Tags:
payer negotiation, drug pricing, PCSK9 inhibitors, Sanofi, Regeneron, Amgen, hepatitis C, Express Scripts
Fidelity, Sanofi back $75M round for Jeremy Levin's neurology startup
Fierce Biotech
Thu, 08/13/15 - 08:41 am
Tags:
Sanofi, OV101, Ovid Therapeutics, neurology
CVS to adopt 'wait and see' approach on PCSK9 cholesterol meds
BioPharma Dive
Mon, 08/10/15 - 10:53 am
Tags:
CVS, PCSK9 inhibitors, formulary, Sanofi, Regeneron, Praluent, Amgen, Repatha
MannKind Cheered Despite Lower Afrezza Shipments
24/7 Wall St
Mon, 08/10/15 - 09:49 am
Tags:
Afrezza, diabetes, insulin, MannKind, Sanofi, inhaled insulin
Sanofi deepens its Evotec ties with a $330M diabetes deal
Fierce Biotech
Sat, 08/8/15 - 01:22 pm
Tags:
Sanofi, Evotec, diabetes, cell replacement therapy
Novo Nordisk says any tussle with Sanofi's Toujeo will come down to formulary access
Medical Marketing and Media
Fri, 08/7/15 - 08:43 am
Tags:
Sanofi, Novo Nordisk, Toujeo, formulary, Tresiba, insulin, diabetes
Will Regeneron's New Drug Break The Bank?
Motley Fool
Wed, 08/5/15 - 09:28 am
Tags:
Regeneron, Praluent, drug pricing, Sanofi
Sanofi and MannKind launch Afrezza DTC ad campaign in stealth mode
Fierce Pharma Marketing
Mon, 08/3/15 - 04:50 pm
Tags:
Sanofi, MannKind, DTC, Afrezza, diabetes, inhaled insulin, insulin
Afrezza sales still underperforming, but MannKind remains optimistic
BioPharma Dive
Fri, 07/31/15 - 11:06 am
Tags:
Afrezza, diabetes, insulin, inhaled insulin, MannKind, Sanofi
With solid Q2, Sanofi CEO says M&A could be part of growth strategy
Fierce Pharma
Fri, 07/31/15 - 11:04 am
Tags:
Sanofi, M&A, Pharma CEOs, Olivier Brandicourt
Sanofi launches DTC campaign for Afrezza
Medical Marketing and Media
Thu, 07/30/15 - 05:22 pm
Tags:
Sanofi, Afrezza, insulin, DTC
Sanofi calls out Genzyme, multiple sclerosis drug, as main drivers of growth again
Bizjournals.com
Thu, 07/30/15 - 10:33 am
Tags:
Sanofi, Genzyme, MS, multiple sclerosis, Aubagio, earnings
MannKind Afrezza Sales Underwhelming Again, Sanofi Reports
TheStreet.com
Thu, 07/30/15 - 10:28 am
Tags:
MannKind, Afrezza, Sanofi, diabetes, insulin, inhaled insulin
Sanofi Profit Beats Estimates as Multiple Sclerosis Drugs Gain
Bloomberg
Thu, 07/30/15 - 10:23 am
Tags:
Sanofi, earnings

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.